Structure Therapeutics, Inc. (GPCR)
25.51
-0.16
(-0.62%)
USD |
NASDAQ |
Oct 09, 15:20
Structure Therapeutics EPS Diluted (Quarterly) : -1.464 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.464 |
| March 31, 2026 | -1.052 |
| December 31, 2025 | 0.56 |
| September 30, 2025 | -1.125 |
| June 30, 2025 | -1.075 |
| March 31, 2025 | -0.8178 |
| December 31, 2024 | -0.6345 |
| September 30, 2024 | -0.5988 |
| June 30, 2024 | -0.5263 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.5582 |
| December 31, 2023 | -0.5316 |
| September 30, 2023 | -0.6228 |
| June 30, 2023 | -0.6021 |
| March 31, 2023 | -0.7511 |
| December 31, 2022 | -0.324 |
| June 30, 2022 | -0.4205 |
| March 31, 2022 | -0.358 |
| December 31, 2021 | -0.4225 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.939 |
| Novo Nordisk A/S | 0.7362 |
| Pfizer Inc. | -0.0435 |
| Viking Therapeutics, Inc. | -1.101 |
| Liquidia Corp. | 0.7369 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -106.33M |
| Total Expenses (Quarterly) | 106.33M |
| Enterprise Value | 491.70M |
| Earnings Yield | -12.08% |
| Normalized Earnings Yield | -12.55 |